Literature DB >> 25172908

Association of polymorphisms in AGTR1 and AGTR2 genes with primary aldosteronism in the Chinese Han population.

Zhun Wu1, Chao Huang1, Tingting Zhou2, Jinglai Lin1, Kaiyan Zhang1, Wei Li1, Jiaxin Zheng1, Bin Chen1, Baojun Wang3, Xu Zhang3, Jinchun Xing4.   

Abstract

HYPOTHESIS: Polymorphisms in angiotensin II type-1/2 receptor genes (AGTR1/AGTR2) may be involved in the pathogenesis of primary aldosteronism. The present study aims to reveal some loci susceptible to the disease on the genes in a group of Chinese Han nationality.
MATERIALS AND METHODS: A case-control study was conducted in 202 patients and 188 controls. Ten tagging SNPs on AGTR1/AGTR2 were genotyped for all subjects via the method of multiplex PCR-ligase detection reaction. Statistical analysis was performed with chi-square test and logistic regression analysis.
RESULTS: rs3772616 on the AGTR1 gene was a factor for susceptibility to primary aldosteronism (p<0.001), and the TT genotype significantly decreased the risk of primary aldosteronism compared with the CC homozygote (p=0.008, adjusted OR=0.13; 95%CI: 0.03-0.59). The rs3772616 polymorphism was associated with primary aldosteronism under the additive and dominant models. The female carriers of the G allele in rs5193 showed a significant difference compared with the T allele.
CONCLUSIONS: The AGTR1 rs3772616 polymorphism can be considered as a hereditary marker for primary aldosteronism, and in the Chinese Han population the rs5193 G allele seems to predispose to it only in women.
© The Author(s) 2014.

Entities:  

Keywords:  AGTR1; AGTR2; RAAS; primary aldosteronism; tagSNPs

Mesh:

Substances:

Year:  2014        PMID: 25172908     DOI: 10.1177/1470320314534511

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


  1 in total

1.  Correlation Between Angiotensin Receptor Type 1 Polymorphisms and Atherosclerotic Cerebral Infarction Risk.

Authors:  Linfa Chen; Ying Wang; Yajun Wang; Shaoting Huang; Zhaochun Wu; Jiawen He; Wangtao Zhong; Bin Zhao; Guoda Ma; You Li
Journal:  Pharmgenomics Pers Med       Date:  2022-05-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.